Endocan Corp Stock Performance
| ENDO Stock | USD 0.0001 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Endocan Corp are completely uncorrelated.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Endocan Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile fundamental indicators, Endocan Corp displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Endocan |
Endocan Corp Relative Risk vs. Return Landscape
If you would invest 0.01 in Endocan Corp on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Endocan Corp or generate 0.0% return on investment over 90 days. Endocan Corp is currently generating 14.2857% in daily expected returns and assumes 126.8186% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Endocan, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Endocan Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Endocan Corp's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Endocan Corp, and traders can use it to determine the average amount a Endocan Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1126
| Best Portfolio | Best Equity | ENDO | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 126.82 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Endocan Corp is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Endocan Corp by adding it to a well-diversified portfolio.
Endocan Corp Fundamentals Growth
Endocan Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Endocan Corp, and Endocan Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Endocan Pink Sheet performance.
| Current Valuation | 1.87 M | |||
| Shares Outstanding | 67.89 M | |||
| Price To Earning | (0.09) X | |||
| Price To Book | 18.51 X | |||
| Cash And Equivalents | 59 | |||
| Total Debt | 954.59 K | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (105.94 K) | |||
| Earnings Per Share | (0.12) X | |||
| Total Asset | 359 | |||
| Retained Earnings | (32.94 M) | |||
| Current Liabilities | 1.49 M | |||
About Endocan Corp Performance
By examining Endocan Corp's fundamental ratios, stakeholders can obtain critical insights into Endocan Corp's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Endocan Corp is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Thermic Sciences International develops and sells hemp based products. Thermic Sciences International was incorporated in 1969 and is based in Colorado Springs, Colorado. ENDOCAN CORP operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange.Things to note about Endocan Corp performance evaluation
Checking the ongoing alerts about Endocan Corp for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Endocan Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Endocan Corp is way too risky over 90 days horizon | |
| Endocan Corp has some characteristics of a very speculative penny stock | |
| Endocan Corp appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (3.31 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Endocan Corp currently holds about 59 in cash with (105.94 K) of positive cash flow from operations. |
- Analyzing Endocan Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Endocan Corp's stock is overvalued or undervalued compared to its peers.
- Examining Endocan Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Endocan Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Endocan Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Endocan Corp's pink sheet. These opinions can provide insight into Endocan Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Endocan Pink Sheet
Endocan Corp financial ratios help investors to determine whether Endocan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Endocan with respect to the benefits of owning Endocan Corp security.